Business Trip

How the DEA and FDA will regulate psychedelic medicine


Listen Later

In this week’s episode, we chat with Matt Zorn, an attorney at Yetter Coleman with expertise in DEA law, especially regarding psychedelics. Matt is currently challenging the DEA’s decision to schedule 5 new tryptamines, he recently argued Kathryn Tucker’s psilocybin “Right To Try” case against the DEA, and previously co-led Sue Sisley’s DEA case related to cannabis scheduling. Matt also writes the drug policy newsletter On Drugs.

Credits

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky & Greg Kubin
Produced by Jonathan A. Davis & Zack Frank

Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank



...more
View all episodesView all episodes
Download on the App Store

Business TripBy Greg Kubin & Matias Serebrinsky

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

50 ratings


More shows like Business Trip

View all
The Bill Simmons Podcast by The Ringer

The Bill Simmons Podcast

30,320 Listeners